title: Do giant parathyroid adenomas represent a distinct clinical entity?
abstract: BACKGROUND
  The size of abnormal parathyroid glands in patients with primary hyperparathyroidism (PHPT) is highly variable, but the clinical significance of giant glands is unknown.
  
  
  METHODS
  We reviewed 300 consecutive patients after parathyroidectomy for PHPT. We compared patients with giant parathyroid adenomas (weight ≥95th percentile) with the remaining patients.
  
  
  RESULTS
  Giant adenomas were defined as weight ≥95th percentile or 3.5 g (median, 0.61; range, 0.05-29.93). Patients with giant adenomas had a greater mean preoperative calcium level, greater mean parathyroid hormone (PTH) level, and were less likely to have multiglandular or symptomatic disease. Giant adenomas were successfully localized on imaging in 87% of patients, which was not increased over other patients (82%). There were no differences between the groups in age, gender, gland location, or the incidence of persistent or recurrent hyperparathyroidism. Finally, giant glands had an increased incidence of symptomatic postoperative hypocalcemia, including 1 patient who required rehospitalization after removal of a giant gland.
  
  
  CONCLUSIONS
  Giant parathyroid adenomas have a distinct presentation characterized by single gland disease and lower incidence of symptoms despite increased levels of calcium and PTH. Additionally, after resection of a giant adenoma, patients are more likely to develop symptomatic hypocalcemia.
authors: Department of Surgery, University of Iowa, Iowa City, IA.
authors: Philip M
authors: PM
authors: Spanheimer
authors: Andrew J
authors: AJ
authors: Stoltze
authors: James R
authors: JR
authors: Howe
authors: Sonia L
authors: SL
authors: Sugg
authors: Geeta
authors: G
authors: Lal
authors: Ronald J
authors: RJ
authors: Weigel
mesh_terms: D000236:Adenoma / Q000097:blood / Q000601:surgery*; D000328:Adult; D000368:Aged; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D010282:Parathyroid Neoplasms / Q000097:blood / Q000473:pathology / Q000601:surgery*
chemical_list: D010281:Parathyroid Hormone; D002118:Calcium
references: J Surg Res. 2009 Jul;155(1):100-3
references: 19135685
references: Nucl Med Commun. 2003 Jul;24(7):755-62
references: 12813193
references: Ann Surg. 2004 May;239(5):704-8; discussion 708-11
references: 15082975
references: Semin Nucl Med. 2005 Oct;35(4):266-76
references: 16150247
references: Surg Clin North Am. 1977 Jun;57(3):557-63
references: 867222
references: Ann Surg Oncol. 2012 Sep;19(9):2958-62
references: 22535262
references: J Bone Miner Res. 1991 Oct;6 Suppl 2:S97-101; discssion S121-4
references: 1763676
references: Ann Surg. 1981 Dec;194(6):671-6
references: 7305478
references: J Clin Endocrinol Metab. 2000 Mar;85(3):1054-8
references: 10720039
references: Otolaryngol Clin North Am. 1996 Aug;29(4):663-79
references: 8844736
references: Am Surg. 2004 Jun;70(6):504-6
references: 15212403
references: Arch Surg. 1996 Aug;131(8):861-7; discussion 867-9
references: 8712911
references: Cancer Treat Res. 2010;153:87-103
references: 19957221
references: World J Surg. 1991 Nov-Dec;15(6):688-92
references: 1767534
references: Ann Surg Oncol. 2012 May;19(5):1446-52
references: 22395991
references: J Clin Endocrinol Metab. 2008 Sep;93(9):3462-70
references: 18544625
references: J Am Coll Surg. 2007 Oct;205(4 Suppl):S38-44
references: 17916517